The alpha-synuclein 5'untranslated region targeted translation blockers: anti-alpha synuclein efficacy of cardiac glycosides and Posiphen (Q33790013)

21221670

29 July 2017

title

The alpha-synuclein 5'untranslated region targeted translation blockers: anti-alpha synuclein efficacy of cardiac glycosides and Posiphen (English)

1 reference

29 July 2017

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6625511&resulttype=core&format=json

Sanghamitra Bandyopadhyay

15 May 2020

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6625511&resulttype=core&format=json

15 May 2020

author name string

Sohan Mikkilineni

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6625511&resulttype=core&format=json

15 May 2020

Ippolita Cantuti-Castelvetri

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6625511&resulttype=core&format=json

15 May 2020

Deborah H Smith

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6625511&resulttype=core&format=json

15 May 2020

Xudong Huang

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6625511&resulttype=core&format=json

15 May 2020

Catherine M Cahill

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6625511&resulttype=core&format=json

15 May 2020

Maria L Maccecchini

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6625511&resulttype=core&format=json

15 May 2020

Debomoy K Lahiri

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6625511&resulttype=core&format=json

15 May 2020

Nigel H Greig

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6625511&resulttype=core&format=json

15 May 2020

publication date

8 January 2011

1 reference

21221670

Journal of Neural Transmission

29 July 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6625511&resulttype=core&format=json

15 May 2020

volume

118

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6625511&resulttype=core&format=json

15 May 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6625511&resulttype=core&format=json

15 May 2020

page(s)

493-507

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6625511&resulttype=core&format=json

Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease

15 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0513-5

A high-throughput drug screen targeted to the 5'untranslated region of Alzheimer amyloid precursor protein mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0513-5

Involvement of precerebellar nuclei in multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0513-5

Exacerbated synucleinopathy in mice expressing A53T SNCA on a Snca null background

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0513-5

Interleukin (IL) 1beta induction of IL-6 is mediated by a novel phosphatidylinositol 3-kinase-dependent AKT/IkappaB kinase alpha pathway targeting activator protein-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0513-5

Amyloid precursor protein and alpha synuclein translation, implications for iron and inflammation in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0513-5

The solubility of alpha-synuclein in multiple system atrophy differs from that of dementia with Lewy bodies and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0513-5

Alpha-synuclein and chaperones in dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0513-5

Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0513-5

Iron-export ferroxidase activity of β-amyloid precursor protein is inhibited by zinc in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0513-5

Alpha-synuclein and neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0513-5

Multiple determinants within iron-responsive elements dictate iron regulatory protein binding and regulatory hierarchy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0513-5

Phenserine and ring C hetero-analogues: drug candidates for the treatment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0513-5

An overview of phenserine tartrate, a novel acetylcholinesterase inhibitor for the treatment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0513-5

Cytotoxic effects of kinetin riboside on mouse, human and plant tumour cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0513-5

Iron-dependent regulation of the divalent metal ion transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0513-5

An inhibitor of the Tat/TAR RNA interaction that effectively suppresses HIV-1 replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0513-5

Novel nonnucleoside inhibitor of hepatitis C virus RNA-dependent RNA polymerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0513-5

Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0513-5

Involvement of alpha-synuclein in Parkinson's disease and other neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0513-5

Differential effects of two hexahydropyrroloindole carbamate-based anticholinesterase drugs on the amyloid beta protein pathway involved in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0513-5

The experimental Alzheimer's disease drug posiphen [(+)-phenserine] lowers amyloid-beta peptide levels in cell culture and mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0513-5

Neurodegenerative disease: amyloid pores from pathogenic mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0513-5

Digoxin blocks tumor growth through HIF-1alpha inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0513-5

Aggregation promoting C-terminal truncation of alpha-synuclein is a normal cellular process and is enhanced by the familial Parkinson's disease-linked mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0513-5

Effects of 12 metal ions on iron regulatory protein 1 (IRP-1) and hypoxia-inducible factor-1 alpha (HIF-1alpha) and HIF-regulated genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0513-5

Calcium(II) selectively induces alpha-synuclein annular oligomers via interaction with the C-terminal domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0513-5

Inhibitory properties of nucleic acid-binding ligands on protein synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0513-5

Modulation of human neural stem cell differentiation in Alzheimer (APP23) transgenic mice by phenserine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0513-5

A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0513-5

The effect of oral iron admiinistration on mycophenolate mofetil absorption in renal transplant recipients: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0513-5

Clinical heterogeneity of alpha-synuclein gene duplication in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0513-5

Effects of oxidative and nitrative challenges on alpha-synuclein fibrillogenesis involve distinct mechanisms of protein modifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0513-5

Individual dopaminergic neurons show raised iron levels in Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0513-5

Physiological and pathological role of alpha-synuclein in Parkinson's disease through iron mediated oxidative stress; the role of a putative iron-responsive element

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0513-5

Drug Discovery Targeted to the Alzheimer's APP mRNA 5'-Untranslated Region: The Action of Paroxetine and Dimercaptopropanol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0513-5

Interaction of human alpha-Synuclein and Parkinson's disease variants with phospholipids. Structural analysis using site-directed mutagenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0513-5

UV-induced modifications in the peptidyl transferase loop of 23S rRNA dependent on binding of the streptogramin B antibiotic, pristinamycin IA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0513-5

Metal and inflammatory targets for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0513-5

An iron-responsive element type II in the 5'-untranslated region of the Alzheimer's amyloid precursor protein transcript

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0513-5

Alzheimer's disease drug discovery targeted to the APP mRNA 5'untranslated region.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0513-5

Iron and the translation of the amyloid precursor protein (APP) and ferritin mRNAs: riboregulation against neural oxidative damage in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0513-5

GATA transcription factors directly regulate the Parkinson's disease-linked gene alpha-synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0513-5

Phenserine regulates translation of beta -amyloid precursor protein mRNA by a putative interleukin-1 responsive element, a target for drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0513-5

alpha-Synuclein locus triplication causes Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0513-5

LRRK2: a common pathway for parkinsonism, pathogenesis and prevention?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0513-5

The up-regulation of ferritin expression using a small-molecule ligand to the native mRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0513-5

RNA therapeutics directed to the non coding regions of APP mRNA, in vivo anti-amyloid efficacy of paroxetine, erythromycin, and N-acetyl cysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0513-5

Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0513-5

Preclinical investigation of the topical administration of phenserine: transdermal flux, cholinesterase inhibition, and cognitive efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0513-5

Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0513-5

Pesticides directly accelerate the rate of alpha-synuclein fibril formation: a possible factor in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0513-5

Biophysical properties of the synucleins and their propensities to fibrillate: inhibition of alpha-synuclein assembly by beta- and gamma-synucleins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0513-5

The integrated role of desferrioxamine and phenserine targeted to an iron-responsive element in the APP-mRNA 5'-untranslated region

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0513-5

Cardiac glycosides provide neuroprotection against ischemic stroke: discovery by a brain slice-based compound screening platform

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0513-5

Excess capacity of the iron regulatory protein system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0513-5

Controlling gene expression in living cells through small molecule-RNA interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0513-5

Deficiency of glutaredoxin 5 reveals Fe-S clusters are required for vertebrate haem synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0513-5

Certain Metals Trigger Fibrillation of Methionine-oxidized α-Synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0513-5

Digoxin and other cardiac glycosides inhibit HIF-1alpha synthesis and block tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0513-5

Small-molecule inhibitors of HIF-2a translation link its 5'UTR iron-responsive element to oxygen sensing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0513-5

Computer prediction of RNA structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0513-5

Cognitive decline correlates with neuropathological stage in Parkinson's disease

21 January 2018

1 reference

12 December 2020

Characterization of the APP proximal promoter and 5'-untranslated regions: identification of cell type-specific domains and implications in APP gene expression and Alzheimer's disease.

1 reference

12 December 2020

The G209A mutation in the alpha-synuclein gene is not detected in familial cases of Parkinson disease in non-Greek and/or Italian populations

1 reference

12 December 2020

The A53T alpha-synuclein mutation increases iron-dependent aggregation and toxicity

1 reference

12 December 2020

Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies.

1 reference

12 December 2020

The 5'-untranslated region of Parkinson's disease alpha-synuclein messengerRNA contains a predicted iron responsive element

1 reference

12 December 2020

Role of cytokines in the gene expression of amyloid β–protein precursor: Identification of a 5'-UTR-Binding nuclear factor and its implications in Alzheimer's disease

1 reference

12 December 2020

Mycophenolate mofetil: An update

1 reference

12 December 2020

Phenserine Efficacy in Alzheimer's Disease

1 reference

12 December 2020

Presence of a "CAGA box" in the APP gene unique to amyloid plaque-forming species and absent in all APLP-1/2 genes: implications in Alzheimer's disease

1 reference

12 December 2020

The spectrum series: grappling with the overlap between Alzheimer's and Parkinson's diseases. 9th International Conference on Alzheimer's and Parkinson's Diseases, 11-15 March 2009, Prague,Czech Republic

1 reference

12 December 2020

Neuropathology, biochemistry, and biophysics of alpha-synuclein aggregation

1 reference

12 December 2020

Targeting RNA with small molecules

1 reference

12 December 2020

Metal specificity of an iron-responsive element in Alzheimer's APP mRNA 5'untranslated region, tolerance of SH-SY5Y and H4 neural cells to desferrioxamine, clioquinol, VK-28, and a piperazine chelator.

1 reference

12 December 2020

Characterization of the human alpha-synuclein gene: Genomic structure, transcription start site, promoter region and polymorphisms.

1 reference

12 December 2020

Hypoxia alters iron-regulatory protein-1 binding capacity and modulates cellular iron homeostasis in human hepatoma and erythroleukemia cells

1 reference

12 December 2020

The experimental Alzheimer drug phenserine: preclinical pharmacokinetics and pharmacodynamics

1 reference

12 December 2020

Neuropathology of Parkinson's disease

1 reference

12 December 2020

Selective translational control of the Alzheimer amyloid precursor protein transcript by iron regulatory protein-1.

1 reference

12 December 2020

Dityrosine cross-linking promotes formation of stable alpha -synuclein polymers. Implication of nitrative and oxidative stress in the pathogenesis of neurodegenerative synucleinopathies

1 reference

12 December 2020

Resistance of alpha -synuclein null mice to the parkinsonian neurotoxin MPTP.

1 reference

12 December 2020

10.1007/S00702-010-0513-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6625511&resulttype=core&format=json

15 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6625511&resulttype=core&format=json

15 May 2020

21221670

1 reference